Advertisement
Advertisement
U.S. markets close in 5 hours 9 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Regencell Bioscience Holdings Limited (RGC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
25.67-0.42 (-1.63%)
As of 10:46AM EST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/27/2021
Current
Market Cap (intraday) 5
337.14M
Enterprise Value 3
340.77M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 7
-251.51

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3148.48%
S&P500 52-Week Change 326.87%
52 Week High 359.00
52 Week Low 36.00
50-Day Moving Average 320.34
200-Day Moving Average 318.61

Share Statistics

Avg Vol (3 month) 3183.68k
Avg Vol (10 day) 328.3k
Shares Outstanding 512.97M
Implied Shares Outstanding 6N/A
Float 81.99M
% Held by Insiders 180.15%
% Held by Institutions 10.16%
Shares Short (Nov 14, 2021) 426.25k
Short Ratio (Nov 14, 2021) 40.51
Short % of Float (Nov 14, 2021) 41.14%
Short % of Shares Outstanding (Nov 14, 2021) 40.21%
Shares Short (prior month Oct 14, 2021) 424.78k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 29, 2021
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-202.15%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -1.35M
Net Income Avi to Common (ttm)-1.35M
Diluted EPS (ttm)-0.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)59.41k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)3.68M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.01
Book Value Per Share (mrq)-0.40

Cash Flow Statement

Operating Cash Flow (ttm)-767.31k
Levered Free Cash Flow (ttm)-283.53k
Advertisement
Advertisement